Physician profile
Sameer B Murali
NPI 1174732291
$93,370.86
in general payments reported to CMS, 2019-2025
11 companies · $92K in 2025
The $92K reported for 2025 was more than what 99% of Obesity Medicine (Internal Medicine) providers received nationally (typical 2025 total: $202).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.40 · 2022: $404 · 2023: $195 · 2024: $431 · 2025: $92K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $81K · Travel and Lodging: $8,231 · Consulting Fee: $2,130 · Food and Beverage: $1,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $80,575.00 |
| Travel and Lodging | $8,231.27 |
| Consulting Fee | $2,130.00 |
| Food and Beverage | $1,939.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $90,089.93 | 2022-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $2,992.28 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Ethicon US, LLC | $91.40 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.87 | 2022 | |
| Hologic Sales and Service, LLC | $32.23 | 2025 | Magtrace |
| Rhythm Pharmaceuticals, INC. | $31.06 | 2023 | Imcivree |
| Phathom Pharmaceuticals, INC. | $30.96 | 2024 | Voquezna |
| Medtronic, INC. | $20.18 | 2024 | Interstim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.10 | 2025 | Jardiance |
| Endo Pharmaceuticals INC. | $15.74 | 2022 | |
| Convatec INC. | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Murali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.